Genomics

1/10 We’re excited to announce the publication of our work with @StanfordMed, examining the premature deaths that would be saved if PRS-guided screening was introduced across seven common disease screening programs nature.com/articles/s4146…

🧬 We recently celebrated a huge milestone with the opening our flagship London office. Now, we’re turning to #TheNextSequence’ - the next stage in our growth journey. We’re excited to share this new chapter with you. Stay tuned! #Genomics #UKInnovation

It also highlights the NHS-backed @ukfuturehealth and insights from our CEO & Co-Founder Peter Donnelly on how genetic sequencing could inform earlier treatment decisions, including statins for people in their 20s & 30s.

The piece explores how polygenic risk scores (PRS) could help identify heart attack risk earlier in life, enabling preventative care and earlier interventions for those most at risk.

We’re delighted Genomics was featured in The i Paper, discussing how advances in genetic risk prediction could reshape how we prevent heart disease — even in younger adults. 📖eu1.hubs.ly/H0sGJXK0 #Genomics #PrecisionMedicine #PRS #Cardiology

@zubirahmed We were thrilled to welcome 50+ senior leaders from pharma, healthcare, private healthcare & government to celebrate our new London office! Hearing Dr Zubir Ahmed MP call Genomics “the jewels in our crown” was a truly exciting moment. Thank you to everyone who joined us!

On Feb 25th, we officially opened our flagship London office in the Knowledge Quarter! 🎉Inaugurated by Dr @ZubirAhmed MP and Steve Bates OBE 📖 Read more: eu1.hubs.ly/H0sJh290

📢[FOR MEDIA] Minister for Health Innovation Dr Zubir Ahmed MP and Executive Chair for the Office of Life Sciences Steve Bates OBE open Genomics’ flagship office, as it unveils Agentic AI capabilities within Mystra drug discovery Platform 📰Press release: bit.ly/3ZRGLgy

On #InternationalDayofWomenandGirlsinScience, we're celebrating the incredible contributions of the women in science-related roles at Genomics. We are proud that women constitute 50% of our colleagues in these critical positions, powering the work we do. Thank you! 💙

10/10 Our thanks as ever to participants and investigators providing source data. Co-authors include @DrJackOSullivan @melisa_chuong @Deborah_J_T @mikeweale @fa7gen Nilesh Samani @DanielJohnWells @VincentPlagnol @gil_mcvean @euanashley @seamusharrison @genemodeller @Genomicsltd.

9/10 We therefore conclude that knowledge of genetic risk, measured using PRS, has the potential to deliver substantial public health benefits when aggregated across conditions, and could reduce premature mortality by tailoring existing screening programs.

1/10 We’re excited to announce the publication of our work with @StanfordMed, examining the premature deaths that would be saved if PRS-guided screening was introduced across seven common disease screening programs nature.com/articles/s4146…

And just like that - the 2026 Festival of Genomics is over.🧬 From hosting a breakfast briefing, to talking about advancing drug discovery on the Multi-Omics stage - we had a fantastic time at #FOG2026 last week in London. See photos of our onsite activities below📷 #Genomics

We are delighted to share that Genomics has been recognised for the second year in a row in the Sunday Times 100 Tech as one of Britain’s fastest-growing private technology companies!🏆 📰Read the full article here: bit.ly/4t5vo1F #Genomics #SundayTimes100 @thetimes